CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Antitumor Activity of HM781-36B, alone or in Combination with Chemotherapeutic Agents, in Colorectal Cancer Cells
Mi Hyun Kang, Sung Ung Moon, Ji Hea Sung, Jin Won Kim, Keun Wook Lee, Hye Seung Lee, Jong Seok Lee, Jee Hyun Kim
Cancer Research and Treatment. 2016;48(1):355-364.   Published online 2015 March 5    DOI: https://doi.org/10.4143/crt.2014.260

Excel Download

Antitumor Activity of HM781-36B, alone or in Combination with Chemotherapeutic Agents, in Colorectal Cancer Cells
Cancer Research and Treatment. 2016;48(1):355-364   Crossref logo
Link1 Link2 Link3

Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer
Cancer Letters. 2011;302(2):155-165   Crossref logo
Link1 Link2

Axitinib alone or in combination with chemotherapeutic drugs exerts potent antitumor activity against human gastric cancer cells in vitro and in vivo
Journal of Cancer Research and Clinical Oncology. 2014;140(9):1575-1583   Crossref logo
Link1 Link2 Link3

562 Antitumor Activity of the Polo-like Kinase (PLK) Inhibitor, TAK-960, Alone and in Combination with Standard Agents Against KRAS WT and MT Colorectal Cancer (CRC) Models
European Journal of Cancer. 2012;48:172-173   Crossref logo
Link1 Link2

Antitumor Effect of PSK at a Distant Site: Tumor-specific Immunity and Combination with Other Chemotherapeutic Agents
Japanese Journal of Cancer Research. 1992;83(7):775-782   Crossref logo
Link1

Synergistic Antitumor Activity of Capecitabine in Combination with Irinotecan
Clinical Colorectal Cancer. 2005;4(5):336-343   Crossref logo
Link1 Link2

Lonidamine Alone and in Combination with Other Chemotherapeutic Agents in the Treatment of Cancer Patients
Oncology. 1984;41(1):108-112   Crossref logo
Link1 Link2

Metabolite identification of a new tyrosine kinase inhibitor, HM781-36B, and a pharmacokinetic study by liquid chromatography/tandem mass spectrometry
Rapid Communications in Mass Spectrometry. 2013;27(11):1183-1195   Crossref logo
Link1 Link2 Link3

Antitumor activity of HM781-36B, a highly effective pan-HER inhibitor in erlotinib-resistant NSCLC and other EGFR-dependent cancer models
International Journal of Cancer. 2011;130(10):2445-2454   Crossref logo
Link1

6632 Characterisation of the response of pancreatic cancer cells to treatment with chemotherapeutic agents alone and in combination with tyrosine kinase inhibitors
European Journal of Cancer Supplements. 2009;7(2):399   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.